Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars

view original post

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q3 CY2025 results , with sales up 10% year on year to $310.6 million. On top of that, next quarter’s revenue guidance ($311 million at the …